Publication | Open Access
Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
246
Citations
21
References
2010
Year
The primary end point of the studies was met, indicating that telavancin is noninferior to vancomycin on the basis of clinical response in the treatment of HAP due to gram-positive pathogens.
| Year | Citations | |
|---|---|---|
Page 1
Page 1